Injective (INJ) has seen its price fall below the 20-day exponential moving average to $7.779 after a rejection at flag resistance, signaling continued bearish momentum. The token's Open Interest sharply declined to $79 million, indicating traders are closing positions amid growing uncertainty. Supply in profit has flattened near $75 million, showing limited recent gains for holders. If the price fails to hold above the 20-day EMA, it may drop toward the $7 demand zone, where buyers might step in to prevent further decline.
Injective (INJ) trades at Rp145.406 on Pluang, showing a 1-day gain of 2.23% as of Oct 28, 2026 05:21 WIB. Despite the recent price dip below the 20-day EMA mentioned in the article, Pluang data indicates a positive short-term movement. Market activity on Pluang shows 58% sell orders and a typical hold time of 38 days, suggesting a mix of cautious trading behavior among investors.
Injective CEO Eric Chen met with officials from the White House, SEC, and CFTC in October 2026 to discuss advancing regulated onchain finance and tokenization of real-world assets (RWAs) in the US. Injective, registered as a transfer agent by the SEC...
Injective (INJ), a digital asset, traded at $7.67 as of 6:56 a.m. ET on Saturday, reflecting a 3.74% decrease over the previous 24 hours. This price movement indicates a short-term decline in investor interest or market volatility affecting INJ. Inve...
Canary Capital submitted a preliminary filing on Sept. 24 for an Injective (INJ) ETF that plans to stake at least 90% of its INJ tokens to earn rewards. The fund's daily net asset value will reflect staking rewards, but no cash rewards will be paid t...
